Activation of PPARγ by synthetic agonists reduced the levels of Th2 cytokines and inhibited AHR, the influx of eosinophils and structural changes in the airway wall in murine OVA-challenge models of asthma (77, 78). The gene discussed is PPARG; the disease is asthma.